The future of cancer severity prediction is likely to be shaped by ongoing research and technological advancements. The integration of multi-omics data, including genomics, proteomics, and metabolomics, promises to provide a more comprehensive understanding of cancer biology. Furthermore, developments in AI and precision medicine will continue to enhance the accuracy and utility of predictive models, ultimately leading to more personalized and effective cancer care.
